Rope-like bands of internal scar tissue that form in 70-90% of patients who undergo abdominal surgery have bedeviled patients and surgeons since medical literature history’s recording of adhesions in 1836.
WALTHAM, Mass. and GELEEN, Netherlands – Temple Therapeutics, a biotechnology company pioneering a female-focused precision medicine approach, release ...
LMTK3 as prognostic marker for ovarian cancer and TTX335o, award-winning drug candidate with tumor-killing activity, presented as game-changing treatment for women.
WALTHAM, Mass. – Temple Therapeutics, a biotechnology company pioneering a female-focused precision medicine approach, presented new in vitro and in v ...
Satisfied Users & 
Approved Press Releases
